Hematologia
#ASCO22 – Estudo randomizado | Terapia tripla, transplante e manutenção até a progressão no mieloma.
13 Jun, 2022 | 14:37hTriplet Therapy, Transplantation, and Maintenance until Progression in Myeloma – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comunicado de imprensa: Improved progression-free survival in multiple myeloma patients following three-drug therapy with autologous stem cell transplant – Dana-Farber Cancer Institute
Comentário no Twitter
DETERMINATION: Among adults with multiple myeloma, continuous lenalidomide maintenance therapy after triplet therapy (RVD, plus ASCT) associated with longer PFS than triplet therapy alone. #ASCO22 https://t.co/YhKgjc1Enz pic.twitter.com/cU8nefokZo
— NEJM (@NEJM) June 5, 2022
Breve revisão | Manejo da terapia antiplaquetária em pacientes com stents coronarianos submetidos a cirurgia não cardíaca.
13 Jun, 2022 | 14:27hDiretrizes BSH para investigação de trombofilia.
6 Jun, 2022 | 11:39hGuidelines for thrombophilia testing: A British Society for Haematology guideline
Diretriz atualizada NIH | Terapia antitrombótica em pacientes com COVID-19.
6 Jun, 2022 | 11:37hAntithrombotic Therapy in Patients With COVID-19 – National Institutes of Health
Estudo de coorte | Risco de câncer hematológico em pacientes com prurido indiferenciado.
31 Mai, 2022 | 11:47hRisk of Hematologic Cancer in Patients With Undifferentiated Pruritus – JAMA Dermatology (link para o resumo – $ para o texto completo)
Comentário: Undifferentiated Pruritus Associated with Increased Risk of Hematologic Cancer – HCP Live
Estudo de coorte | Características e história natural da amiloidose cardíaca por transtirretina em estágio inicial.
30 Mai, 2022 | 13:07hEditorial: Early-stage amyloid transthyretin cardiomyopathy: uncertainties and opportunities
Comentário no Twitter
The natural history of Transthyretin Amyloid Cardiomyopathy (ATTR-CM): disease course and clinical outcome among patients diagnosed with early-stage of disease!#amyloid #heart #failure #cardiac #amyloidosis@escardio @ESC_Journals
https://t.co/uvydC3gisD pic.twitter.com/ooKyjeGVNe
— EHJ Editor-in-Chief (@ehj_ed) May 25, 2022
Sob licença de https://creativecommons.org/licenses/by-nc/4.0/
Navegando pela toxicidade financeira em pacientes com câncer: uma abordagem de tratamento multidisciplinar.
27 Mai, 2022 | 13:37hConteúdos relacionados:
Not Just Nausea And Vomiting: Cancer Docs Now Worry About ‘Financial Toxicity’ – WBUR
Financial Toxicity and Cancer Treatment (PDQ®) – National Institute of Cancer
Segunda revisão do International Staging System (R2-ISS) para sobrevida geral no mieloma múltiplo.
27 Mai, 2022 | 13:23hEstudo de coorte | Risco de tromboembolismo venoso em homens com câncer de próstata em comparação com homens na população geral.
26 Mai, 2022 | 12:56hComunicado de imprensa: Men with prostate cancer have a higher risk of serious blood clots – BMJ
Comentário no Twitter
Men with prostate cancer have a 50% higher risk of developing venous thrombosis during the 5 years following their cancer diagnosishttps://t.co/RrYAB5lSrb pic.twitter.com/VGMI7GILgE
— K Pavithran (@drkpavithran) May 24, 2022
Sob licença de http://creativecommons.org/licenses/by-nc/4.0/
BIOIRON Society recomenda nova classificação da hemocromatose.
25 Mai, 2022 | 13:38hComunicado de imprensa: BIOIRON Society Recommends New Classification of Hemochromatosis – ASH Clinical News
Ver diretriz: Hemochromatosis classification: update and recommendations by the BIOIRON Society – Blood